Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis

Vaccine

Volumn 23, Issue 11, 2005, Pages 1393-1398

  Cardona, Pere Joan ^a   Amat, Isabel ^a   Gordillo, Sergi ^a   Arcos, Virginia ^a   Guirado, Evelyn ^a   Díaz, Jorge ^a   Vilaplana, Cristina ^a   Tapia, Gustavo ^b   Ausina, Vicenç ^a  

^a Unitat de Tuberculosi Experimental   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Chemotherapy; Histological analysis; Immunotherapy

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; ISONIAZID; LIPOSOME; MYCOBACTERIUM VACCINE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL CELL; CHEMOTHERAPY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; EOSINOPHILIA; FEMALE; GRANULOMA; HISTOPATHOLOGY; IMMUNOTHERAPY; INBRED STRAIN; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TISSUE NECROSIS; TUBERCULOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTITUBERCULAR AGENTS; COLONY COUNT, MICROBIAL; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERFERON TYPE II; ISONIAZID; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SPLEEN; TUBERCULOSIS; TUBERCULOSIS VACCINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12344310949     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.008     Document Type: Article

References (28)

1. World Health Organization. Global Tuberculosis Control. WHO Report 2001, Geneva, Switzerland, WHO/CDS/TB/2001.287.
2. A.F. Cunningham, and C.L. Spreadbury Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog J Bacteriol 180 1998 801 808
3. T.M. Michele, C. Ko, and W.R. Bishai Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistors Antimicrob Agents Chemother 43 1999 218 225
4. P. Andersen, D. Askgaard, L. Ljungqvist, M.W. Bentzon, and I. Heron T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis Infect Immun 59 1991 1558 1563
5. J. Grosset Bacteriologic basis of short-course chemotherapy for tuberculosis Clin Chest Med 1 1980 231 241
6. A.L. Moreira, L. Tsenova, M.H. Aman, L.G. Bekker, S. Freeman, and B. Mangaliso Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice Infect Immun 70 2002 2100 2107
7. J. Turner, E.R. Rhoades, M. Keen, J.T. Belisle, A.A. Frank, and I.M. Orme Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode Infect Immun 68 2000 1706 1709
8. P.J. Cardona, S. Gordillo, J. Diaz, G. Tapia, I. Amat, and A. Pallares Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis Infect Immun 71 2003 5845 5854
9. M.G. Sonnenberg, and J.T. Belisle Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry Infect Immun 65 1997 4515 4524
10. T. Rabilloud Mechanisms of protein silver staining in polyacrylamide gels: a 10-year synthesis Electrophoresis 11 1990 785 794
11. E. Medina, and R.J. North Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype Immunology 93 1998 270 274
12. S. Cobbold, and H. Waldmann Infectious tolerance Curr Opin Immunol 10 1998 518 524
13. S.B. Lucas, and Histopathology Davies PDO Clinical tuberculosis 1998 Chapman & Hall London 113 127
14. R.M. McCune, F.M. Feldmann, H.P. Lambert, and W. McDermott Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues J Exp Med 123 1966 445 468
15. I. Orme The latent tuberculosis bacillus (I'll let you know if I ever meet one) Int J Tuberc Lung Dis 5 2001 589 593
16. C.A. Scanga, V.P. Mohan, H. Joseph, K. Yu, J. Chan, and J.L. Flynn Reactivation of latent tuberculosis: variations on the Cornell murine model Infect Immun 67 1999 4531 4538
17. P.J. Cardona, E. Julian, X. Valles, S. Gordillo, M. Munoz, and M. Luquin Production of antibodies against glycolipids from the Mycobacterium tuberculosis cell wall in aerosol murine models of tuberculosis Scand J Immunol 55 2002 639 645
18. S.L. Swain, M. Croft, C. Dubey, L. Haynes, P. Rogers, and X. Zhang From naive to memory T cells Immunol Rev 150 1996 143 167
19. C.A. Power, G. Wei, and P.A. Bretscher Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route Infect Immun 66 1998 5743 5750
20. R. Hernandez-Pando, L. Pavon, K. Arriaga, H. Orozco, V. Madrid-Marina, and G. Rook Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection Infect Immun 65 1997 3317 3327
21. V. Gruppo, and I.M. Orme Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis Tuberculosis (Edinb) 82 2002 267 273
22. R. Hernandez-Pando, H. Orozco, K. Arriaga, A. Sampieri, J. Larriva-Sahd, and V. Madrid-Marina Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis Immunology 90 1997 607 617
23. R. Koch, and Weitere Mitteilungen uber ein Heilmittel gegen Tuberku-lose Dtsch Med Wochenschr 16 1890 1029 1032
24. Roach TIA, C.H. Barton, D. Chatterjee, and J.M. Blackwell Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE and tumor necrosis factor-α J Immunol 150 1993 1886 1896
25. T.E. Karplus, R.J. Ulevitch, and C.B. Wilson A new method for reduction of endotoxin contamination from protein solutions J Immunol Methods 105 1987 211 220
26. P.J. Cardona, R. Llatjos, S. Gordillo, J. Diaz, B. Viñado, and A. Ariza Towards a 'human-like' model of tuberculosis: intranasal inoculation of LPS induces intragranulomatous lung necrosis in mice infected aerogenically with Mycobacterium tuberculosis Scand J Immunol 53 2001 65 71
27. P.A. Stumbles, A.S. McWilliam, and P.G. Holt Dendritic cells and mucosal macrophages P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.R. McGhee Mucosal immunology 1999 Academic Press San Diego 397 412
28. A. Williams, R. Reljic, I. Naylor, S.O. Clark, G. Falero-Diaz, and M. Singh Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs Immunology 111 2004 328 333